Assistant Professor
Cardiology
Dr. Anand K. Rohatgi, MD
|
|
Give Review
Anand Rohatgi practices Cardiology. He studied medicine at Duke University School of Medicine. Duke University School of Medicine is a top medical college. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Anand Rohatgi is a published doctor and has 40 publications published. The lastest was: 'Cholesterol Efflux Capacity as a Therapeutic Target: Rationale and Clinical Implications.' Dr. Anand K. Rohatgi is registered with Medicare and accepts Medicare payments.
Publications
- Coronary Artery Calcium Improves Risk Classification in Younger Populations.
- Cholesterol Efflux Capacity as a Therapeutic Target: Rationale and Clinical Implications.
- Applying a Big Data Approach to Biomarker Discovery: Running Before We Walk?
- Relation of Black Race Between High Density Lipoprotein Cholesterol Content, High Density Lipoprotein Particles and Coronary Events (from the Dallas Heart Study).
- The association of abnormal findings on transthoracic echocardiography with 2011 Appropriate Use Criteria and clinical impact.
- HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events.
- The relationship of body mass and fat distribution with incident hypertension: observations from the dallas Heart study.
- Coronary Artery Calcification and Family History of Myocardial Infarction in the Dallas Heart Study.
- The role of advanced lipid testing in the prediction of cardiovascular Disease.
- Appropriate Use and Clinical Impact of Transthoracic Echocardiography.
- Discordant effects of rosiglitazone on novel inflammatory biomarkers.
- Association of chronic lung disease with treatments and outcomes patients with Acute myocardial infarction.
- Addition of highly sensitive troponin T and N-terminal pro-B-type natriuretic Peptide to electrocardiography for detection of left ventricular hypertrophy: results fro...
- Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults.
- Cardiovascular lifetime risk predicts incidence of Coronary calcification in individuals with low short-term risk: the dallas heart study.
- Association of growth differentiation factor-15 with Coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.
- Circulating levels of matrix metalloproteinase-9 and abdominal Aortic pathology: from the Dallas Heart Study.
- Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas Heart Study.
- Interactions Between Smoking, Pulmonary Surfactant Protein B, and Atherosclerosis in the General Population: The Dallas Heart Study.
- Risk scores versus natriuretic peptides for identifying prevalent stage B Heart failure.
- Lifetime risks for cardiovascular Disease mortality by cardiorespiratory fitness levels measured at ages 45, 55, and 65 years in men. The Cooper Center Longitudinal St...
- Cardiorespiratory fitness and classification of risk of cardiovascular Disease mortality.
- Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.
- Body size misperception: a novel determinant in the obesity epidemic.
- Assessing clinical utility of Carotid intima-media thickness on the basis of reclassification.
- Circulating lymphotoxin β receptor and atherosclerosis: observations from the Dallas Heart Study.
- Separating the contenders from the pretenders: competitive high-throughput biomarker screening in large population-based studies.
- Cholesterol screening in children: makes sense but what is the impact?
- Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: results from the dallas Heart study.
- The report card on growth differentiation factor 15: consistent marks but not yet ready for promotion.
- Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selec...
- Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.
- The association between peptidoglycan recognition protein-1 and Coronary and peripheral atherosclerosis: Observations from the Dallas Heart Study.
- The association between plasma caspase-3, atherosclerosis, and vascular function in the Dallas Heart Study.
- Effects of the thiazolidinedione medications on micro- and macrovascular complications in patients with diabetes--update 2008.
- Hyperthyroidism-associated coronary vasospasm with myocardial infarction and subsequent euthyroid Angina.
- HDL cholesterol: physiology, pathophysiology, and management.
- Plasma cytokines, metabolic Syndrome, and atherosclerosis in humans.
- Resistin is an inflammatory marker of atherosclerosis in humans.
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Blue Choice
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Emblem Health
- First Health (Coventry Health Care) PPO
- Golden Rule
- Health Alliance
- HealthSmart
- Choice Care PPO
- Preferred PPO
- Mail Handlers Benefit Plan (MHBP)
- MedHealthInsurance
- Medicaid
- Medicare MCR
- Molina
- PHCS Network PPO
- UniCare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
University of Texas Southwestern Medical School -
University of Pennsylvania Health System -
Duke University School of Medicine
Hospital
-
Parkland Health & Hospital System -
University of Texas Southwestern Medical Center
Drug Facts
| NPI NUMBER | 1427173533 | |
| NPPES Provider LastName | ROHATGI | |
| NPPES Provider FirstName | ANAND | |
| NPPES Provider ZIPCode | 753909047 | |
| NPPES Provider State | TX | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 1071.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427173533 |
| Last Name Of The Provider | ROHATGI |
| First Name Of The Provider | ANAND |
| View All |
Similar Doctors
|
|
Dr. Monica Y. Lo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Boehrer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Liao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramy F. Ayad, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Dian J. Cao, MD |
|
|
Dr. John Hyland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul A. Aggarwal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi Chandrasekhara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gautam R. Patankar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rahul B. Thomas, MD |
|
|
Peter Kunkel, PA
This Doctor is OpenDoctor Recommended.
|